E

Highlights from Day 2 AACR-NCI-EORTC #TARGETS17

A look at some of the important data coming out of Day 2 of #Targets17 in Philadelphia

October 28, 2017
E

SITC 2016 Can Nektar Boost Checkpoint Performance

Without effector T cells in the tumour, checkpoints won't work. So how do we attract more in? Here's one way to do it...

November 16, 2016
E

SITC 2016 New Immunotherapy Drug Development

A look at new ways to boost checkpoint therapy performance including agents in development from small biotechs

November 17, 2016
E

SITC 2016 Update on the Competitive Urothelial Cancer Market

Update on important new data in urothelial cancers and how the landscape is moving quickly

November 15, 2016
E
National Harbor Maryland

Red Flags in SITC Lirilumab plus Nivolumab Head and Neck Cancer Data

Does adding lirilumab to nivolumab move the needle in relapsed SCCHN?

November 14, 2016